- Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. Curti, B.D., Ochoa, A.C., Powers, G.C., Kopp, W.C., Alvord, W.G., Janik, J.E., Gause, B.L., Dunn, B., Kopreski, M.S., Fenton, R., Zea, A., Dansky-Ullmann, C., Strobl, S., Harvey, L., Nelson, E., Sznol, M., Longo, D.L. J. Clin. Oncol. (1998)